Navigation Links
Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting

pment for the treatment of advanced ovarian cancer and non-small cell lung cancer. A second drug development candidate, TELINTRA(TM) (TLK199), is in clinical development in myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at www.telik.com.

This press release contains "forward-looking" statements, including statements regarding the potential for TELCYTA to treat one or more types of cancer. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, that none of Telik's product candidates have been determined to be safe or effective in humans or been approved for marketing, clinical trials of Telik's product candidates may take several years to complete and may not be successful, success in preclinical testing and early clinical trials does not ensure that later clinical trials will be successful and interim results of clinical trials do not necessarily predict final results. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its annual report on Form 10-K for the year ended December 31, 2006. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

NOTE: TELIK, the Telik logo, TELCYTA, TELINTRA and TRAP are trademarks or registered trademarks of Telik, Inc.

CONTACT: Carol D. DeGuzman, Senior Director, Corporate Communications ofTelik, +1-650-845-7728, or '"/>




Page: 1 2 3

Related medicine technology :

1. Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... into a new clinical affiliation with MedStar Health, a ... Maryland and the Washington, ... high-quality, affordable health care services for patients. Through this ... access to clinical support, medication counseling, chronic disease monitoring ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
... 2010 Curemark LLC , a drug research and ... today that it has been awarded a grant by the ... Program to advance the development of its lead product CM-AT ... at 18 sites around the US. The QTDP ...
... VALLEY, Calif., Nov. 2, 2010 Spectros Corporation ... with the T-Stat VLS Tissue Oximeter at the ... newly released data was presented during poster sessions ... Circulation: Pharmacology/Physiology", held at the American Society of ...
Cached Medicine Technology:Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant 2Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010 2
(Date:8/27/2014)... August 28, 2014 Recently, iFitDress.com, a ... announced its new designs of romantic bridal gowns ... enjoy a promotional price (up to 66 percent off) ... the company’s product line has been updated with these ... and patient. iFitDress.com hopes that all clients can gain ...
(Date:8/27/2014)... Calif. (PRWEB) August 27, 2014 Seventy-three ... of Pharmacy (SoP) celebrated the beginning of their careers ... on Saturday, August 23. Students entering a four-year PharmD ... and care ?to welcome them into the profession as ... the ceremony held at the Garrison Theater in Claremont, ...
(Date:8/27/2014)... 2014 Ticket Down is a ... at Levi’s Stadium in Santa Clara. Levi’s Stadium is ... just opened in July and will host their first international ... Chile. These are two of the best teams that are ... and will look to continue their successes from the tournament ...
(Date:8/27/2014)... Dr. Stewart Shofner and ... of patients suffering from impaired vision. Some of the ... correction surgery . Recently, Dr. Shofner has noticed a ... eye exam and also online. To help patients understand ... about glaucoma. , 1)    Myth: People with perfect vision won’t ...
(Date:8/27/2014)... New York (PRWEB) August 27, 2014 ... our society today, big business has taken notice. With ... form of medical cannabis friendly legislation on their books ... While states such as New York and Florida are ... their medical marijuana laws a void of reliable information ...
Breaking Medicine News(10 mins):Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:The Marijuana Real Estate Market Opens Up 2Health News:The Marijuana Real Estate Market Opens Up 3
... release is available in Spanish . , ... that, for the first time since the report was first ... cancers combined are decreasing for both men and women, driven ... of cancer. The report notes that, although the decreases ...
... Chantel ,Chani, Christie, teen,pop star, and daughter of NBA power couple ... Foundation on December 1, 2008 which is World AIDS,Day. To kick ... bestselling,book, ,I Want To Live: A Teenager,s Guide To Finding Self ... education and awareness. , "It ...
... women lagging behind men, study finds , , TUESDAY, Nov. 25 ... system that gives preference to patients with the greatest need, ... among those waiting for new livers are narrowing. , Blacks ... too sick for a transplant while on the waiting list, ...
... (Bayer) has agreed to pay the United States$97.5 million ... to a number of diabetic suppliers and caused those ... Department announced today. The settlement resolves allegations that ... company paid 11 diabetic suppliers to convert their patients ...
... spent at least 14 hours a week taking care ... is the unexpected finding of a University of Michigan ... of the Association for Psychological Science. , The study ... and longevity, it really is better to give than ...
... across race, education levels, and could affect quality of ... News) -- How well a person on Medicare understands ... a new study says. , The report, published ... , found that a third of the surveyed Medicare ...
Cached Medicine News:Health News:Annual report to the nation finds declines in cancer incidence and death rates 2Health News:Annual report to the nation finds declines in cancer incidence and death rates 3Health News:Annual report to the nation finds declines in cancer incidence and death rates 4Health News:Annual report to the nation finds declines in cancer incidence and death rates 5Health News:Teen Pop Star, Chantel 'Chani' Christie, Launches the Chani Girl Foundation to Bring Education/Awareness on HIV/AIDS 2Health News:New System Improves Distribution of Donated Livers 2Health News:New System Improves Distribution of Donated Livers 3Health News:Bayer Healthcare to Pay U.S. $97.5 Million to Settle Allegations of Paying Kickbacks to Diabetic Suppliers 2Health News:In sickness and health: Caring for ailing spouse may prolong your life 2
... a service that directly connects the ... customers laboratory to the Thermo Electron ... and Runcorn, U.K.* By using a ... site, high-value support services are made ...
The Shandon Citadel is a low cost, reliable, time-tested carousel-type tissue processor with convenient touch key operation. The Citadel 2000 has 110 cassette capacity and the Citadel 1000 has a cap...
... Grosslab Senior Grossing Wokrstation is a ... designed for gross examination and sectioning ... construction, 3 efficient ventilation systems and ... for water faucets, table rinses, disposals ...
The HypercleanTM 1 is a versatile, durable fume handling station. The Hyperclean 1 fume handling station unit comes complete with one (1) blower unit and one (1) charcoal filter....
Medicine Products: